|
|
||||||||
Departments of Medicine and Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710
Received 19 August 1996; accepted in final form 31 March 1997.
Simonson, Steven G., Karen E. Welty-Wolf, Yuh-Chin T. Huang,
David E. Taylor, Stephen P. Kantrow, Martha S. Carraway, James D. Crapo, and Claude A. Piantadosi. Aerosolized
manganese SOD decreases hyperoxic pulmonary injury in primates. I. Physiology and biochemistry. J. Appl.
Physiol. 83(2): 550-558, 1997.
Prolonged hyperoxia causes lung injury and
respiratory failure secondary to oxidative tissue damage mediated, in
part, by the superoxide anion. We hypothesized that aerosol treatment
with recombinant human manganese superoxide dismutase (rhMnSOD) would
attenuate hyperoxic lung damage in primates. Adult baboons were
anesthetized and ventilated with 100% oxygen for 96 h or until death.
Six animals were treated with aerosolized rhMnSOD (3 mg · kg
1 · day
1
in divided doses), and six control animals did not receive enzyme therapy. Physiological variables were recorded every 12 h, and ventilation-perfusion ratio relationships were evaluated by using the
multiple inert-gas elimination technique. After the experiments, surfactant composition and lung edema were measured. We found that
rhMnSOD significantly decreased pulmonary shunt fraction (P < 0.01) and preserved arterial
oxygenation (P < 0.01) during hyperoxia. The rhMnSOD increased lung phospholipids,
phosphatidylcholine and disaturated phosphatidylcholine, and decreased
lung edema in this model. Testing of higher and lower doses of MnSOD (1 and 10 mg · kg
1 · day
1)
in two other groups of baboons produced variable physiological protection, suggesting a "window" of effective dosage. We
conclude that aerosolized MnSOD (3 mg · kg
1 · day
1)
affords significant preservation of pulmonary gas exchange during hyperoxic lung injury.
antioxidant enzymes; superoxide dismutase; oxygen; acute respiratory distress syndrome; acute lung injury
This article has been cited by other articles:
![]() |
R. C.G. Martin, Q. Liu, J. M. Wo, M. B. Ray, and Y. Li Chemoprevention of Carcinogenic Progression to Esophageal Adenocarcinoma by the Manganese Superoxide Dismutase Supplementation Clin. Cancer Res., September 1, 2007; 13(17): 5176 - 5182. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ray Protection of Epithelial Cells by Keratincoyte Growth Factor Signaling Proceedings of the ATS, October 1, 2005; 2(3): 221 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Paine III, S. E. Wilcoxen, S. B. Morris, C. Sartori, C. E. O. Baleeiro, M. A. Matthay, and P. J. Christensen Transgenic Overexpression of Granulocyte Macrophage-Colony Stimulating Factor in the Lung Prevents Hyperoxic Lung Injury Am. J. Pathol., December 1, 2003; 163(6): 2397 - 2406. [Abstract] [Full Text] |
||||
![]() |
J. D. Crapo Redox Active Agents in Inflammatory Lung Injury Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1027 - 1028. [Full Text] |
||||
![]() |
C. E. O. Baleeiro, S. E. Wilcoxen, S. B. Morris, T. J. Standiford, and R. Paine III Sublethal Hyperoxia Impairs Pulmonary Innate Immunity J. Immunol., July 15, 2003; 171(2): 955 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Kinnula and J. D. Crapo Superoxide Dismutases in the Lung and Human Lung Diseases Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1600 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Oury, L. M. Schaefer, C. L. Fattman, A. Choi, K. E. Weck, and S. C. Watkins Depletion of pulmonary EC-SOD after exposure to hyperoxia Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L777 - L784. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Clayton, M. S. Carraway, H. B. Suliman, E. D. Thalmann, K. N. Thalmann, D. E. Schmechel, and C. A. Piantadosi Inhaled carbon monoxide and hyperoxic lung injury in rats Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L949 - L957. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cuzzocrea, D. P. Riley, A. P. Caputi, and D. Salvemini Antioxidant Therapy: A New Pharmacological Approach in Shock, Inflammation, and Ischemia/Reperfusion Injury Pharmacol. Rev., March 1, 2001; 53(1): 135 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Pryhuber, D. P. O'Brien, R. Baggs, R. Phipps, H. Huyck, I. Sanz, and M. H. Nahm Ablation of tumor necrosis factor receptor type I (p55) alters oxygen-induced lung injury Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L1082 - L1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Welty-Wolf, S. G. Simonson, Y.-C. T. Huang, S. P. Kantrow, M. S. Carraway, L.-Y. Chang, J. D. Crapo, and C. A. Piantadosi Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. II. Morphometric analysis J Appl Physiol, August 1, 1997; 83(2): 559 - 568. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |